MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash
$20,600K
Accounts receivable
$7,724K
Prepaid expenses and
other current assets
$2,368K
Inventory
$1,974K
Deferred r&d services,
current portion (note...
$1,374K
Collaboration receivable,
billed and unbilled
$89K
Total current assets
$34,129K
Deferred r&d services,
non-current portion (note...
$2,354K
Finance lease
right-of-use asset
$1,009K
Other non-current
assets
$640K
Operating lease
right-of-use asset
$463K
Property and equipment,
net
$191K
Total assets
$38,786K
Total liabilities and
stockholders equity
$38,786K
Total liabilities
$22,731K
Total stockholders
equity
$16,055K
Accumulated deficit
-$334,595K
Total current
liabilities
$16,219K
R&d funding
liability (note 10)
$5,814K
Finance lease liability
$546K
Operating lease liability
$152K
Additional paid-in capital
$350,648K
Common stock, 0.0001
par value...
$2K
Accrued expenses and
other current...
$12,251K
Accounts payable
$2,193K
Deferred revenue
$1,031K
Finance lease liability
$396K
Operating lease liability
$348K
Back
Back
Balance Sheet
source: myfinsight.com
Verrica Pharmaceuticals Inc. (VRCA)
Verrica Pharmaceuticals Inc. (VRCA)